Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Sarin

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|November 15, 1986
Evidence for HTLV-III/LAV expression by primary cultures of T8 cellsM Fouchard, B Reveil, K Mbayo, et al.
Journal of Virology|October 1, 1973
Properties of noninfectious and transforming viruses released by Murine sarcoma virus-induced hamster tumor cellsA F Gazdar, E Russell, P S Sarma, et al.
Cancer Research|September 1, 1985
Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell lineD Zagury, M Fouchard, R Cheynier, et al.
Science (New York, N.Y.)|February 21, 1986
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDSD Zagury, J Bernard, R Leonard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analoguesS Agrawal, T Ikeuchi, D Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virusS Agrawal, J Goodchild, M P Civeira, et al.
Journal of Clinical Immunology|November 1, 1988
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind studyY Sei, P H Tsang, J P Roboz, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17D H Zimmerman, J T Ulrich, C Wright, et al.
Biochemical Pharmacology|October 15, 1988
Differential modulation of host cell and HIV gene expression by combinations of avarol and AZT in vitroH C Schröder, P S Sarin, M Rottmann, et al.
Lancet (London, England)|November 30, 1985
HTLV-I and HTLV-III antibodies and tropical spastic paraparesisP Rodgers-Johnson, D C Gajdusek, O S Morgan, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|November 15, 1986
Evidence for HTLV-III/LAV expression by primary cultures of T8 cellsM Fouchard, B Reveil, K Mbayo, et al.
Journal of Virology|October 1, 1973
Properties of noninfectious and transforming viruses released by Murine sarcoma virus-induced hamster tumor cellsA F Gazdar, E Russell, P S Sarma, et al.
Cancer Research|September 1, 1985
Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell lineD Zagury, M Fouchard, R Cheynier, et al.
Science (New York, N.Y.)|February 21, 1986
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDSD Zagury, J Bernard, R Leonard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analoguesS Agrawal, T Ikeuchi, D Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virusS Agrawal, J Goodchild, M P Civeira, et al.
Journal of Clinical Immunology|November 1, 1988
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind studyY Sei, P H Tsang, J P Roboz, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17D H Zimmerman, J T Ulrich, C Wright, et al.
Biochemical Pharmacology|October 15, 1988
Differential modulation of host cell and HIV gene expression by combinations of avarol and AZT in vitroH C Schröder, P S Sarin, M Rottmann, et al.
Lancet (London, England)|November 30, 1985
HTLV-I and HTLV-III antibodies and tropical spastic paraparesisP Rodgers-Johnson, D C Gajdusek, O S Morgan, et al.
Pageof 12